ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $111,000 | -47.1% | 27,177 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $210,000 | +92.7% | 58,940 | +97.1% | 0.00% | 0.0% |
| Q3 2021 | $109,000 | -20.4% | 29,904 | -5.1% | 0.00% | 0.0% |
| Q2 2021 | $137,000 | +30.5% | 31,523 | +23.5% | 0.00% | -75.0% |
| Q1 2021 | $105,000 | +2.9% | 25,534 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $102,000 | +47.8% | 25,534 | +0.5% | 0.00% | +33.3% |
| Q3 2020 | $69,000 | -2.8% | 25,414 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $71,000 | +6.0% | 25,978 | -9.0% | 0.00% | +50.0% |
| Q1 2020 | $67,000 | -50.0% | 28,552 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $134,000 | +41.1% | 28,418 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $95,000 | +1.1% | 28,418 | -0.8% | 0.00% | 0.0% |
| Q2 2019 | $94,000 | +38.2% | 28,650 | +27.2% | 0.00% | 0.0% |
| Q1 2019 | $68,000 | +15.3% | 22,521 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $59,000 | +1.7% | 21,766 | -2.4% | 0.00% | +100.0% |
| Q2 2018 | $58,000 | +38.1% | 22,299 | +17.2% | 0.00% | 0.0% |
| Q1 2018 | $42,000 | +10.5% | 19,020 | -1.0% | 0.00% | 0.0% |
| Q4 2017 | $38,000 | -35.6% | 19,203 | +4.8% | 0.00% | -50.0% |
| Q3 2017 | $59,000 | +5.4% | 18,326 | +5.2% | 0.00% | 0.0% |
| Q2 2017 | $56,000 | +300.0% | 17,428 | +6.8% | 0.00% | +100.0% |
| Q1 2016 | $14,000 | -22.2% | 16,323 | +9.7% | 0.00% | -50.0% |
| Q4 2015 | $18,000 | -33.3% | 14,879 | -7.9% | 0.00% | -33.3% |
| Q3 2015 | $27,000 | -18.2% | 16,157 | +0.9% | 0.00% | 0.0% |
| Q2 2015 | $33,000 | +3.1% | 16,010 | +34.9% | 0.00% | -25.0% |
| Q1 2015 | $32,000 | +10.3% | 11,871 | +4.1% | 0.00% | -20.0% |
| Q4 2014 | $29,000 | +38.1% | 11,405 | +0.2% | 0.01% | +66.7% |
| Q3 2014 | $21,000 | -30.0% | 11,386 | -0.0% | 0.00% | -40.0% |
| Q2 2014 | $30,000 | -26.8% | 11,390 | -2.2% | 0.01% | -28.6% |
| Q1 2014 | $41,000 | -21.2% | 11,649 | -0.5% | 0.01% | -22.2% |
| Q4 2013 | $52,000 | – | 11,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |